EVM is a specialised group within the European Federation of Pharmaceutical Industries and Associations (EFPIA), the professional association of the European pharmaceutical industry.
Formed in 1991 to improve public health through immunization and promoting R&D of innovative vaccines, EVM represents major European vaccine producers accounting for the majority of the vaccines used worldwide.
EVM Members are dedicated to improve public health through immunization and to promote R&D of innovative vaccines.
H1N1 vaccines frequently askded questions - 24 June 2009
European Medicines Agency prepares for approval of pandemic vaccines - 30 April 2009
EVM statement on meeting with Commissioner Vassiliou regarding novel influenza virus - 29 April 2009
EVM Statement regarding Swine Infuenza outbreak - 28 April 2009
[No recent event]